Asston Pharma Approves Audited Financials for FY26

Asston Pharmaceuticals Ltd's Board of Directors approved the audited financial statements and financial results along with the audit report for the financial year and half year ended March 31, 2026, during their meeting held on May 29, 2026. The meeting, conducted via video conferencing, commenced at 03:00 P.M. and concluded at 07:10 P.M. The auditors, Panchal S K & Associates, have issued an independent auditor's report stating that the financial results present a true and fair view in conformity with accounting standards.